Obesity in women of reproductive age and its relation to polycystic ovarian syndrome and sub-fertility

Authors

  • Parween Saadi Ali Department of Obstetric and Gynecology, College of Medicine, Hawler Medical University, Erbil, Iraq.
  • Ghada Alsakkal Department of Obstetric and Gynecology, College of Medicine, Hawler Medical University, Erbil, Iraq.

DOI:

https://doi.org/10.15218/zjms.2024.51

Keywords:

Obesity, Sub-Fertility, Polycystic ovary syndrome, BMI, Reproductive age

Abstract

Background and objective: The Sub-fecundity and infertility are both enhanced by obesity. Regardless of the method of conception, obese women have less favourable reproductive results, and poorer fertility prognosis. One of the main reasons for infertility is polycystic ovarian syndrome (PCOS). The purpose of this study is to determine how obesity and polycystic ovarian syndrome affect fertility in women of reproductive age.

Methods: A cross-sectional study was performed at a maternity teaching hospital in Erbil, Kurdistan Region, Iraq. It comprises 400 women: 200 with a BMI of 30 or above and 200 with a BMI between 18 and 24. From January 1, 2021, until December 31, 2021.

Results: The average age of the enrolled women was 29.9 years. The majority (81.5%) were under 30 years of age, and (70.6%) were classified as overweight. In the obese group, 55% of women had never experienced pregnancy. A greater percentage of the obese group had no history of miscarriage in comparison to the non-obese group. The obese group exhibited a significantly higher prevalence of hirsutism (59%) compared to the non-obese group (39.5%). Infertility rates varied from 84% in the obese group to 38.5% in the non-obese group. In contrast to 44.5% of non obese women, the ultrasonographic findings indicated that 60% of obese women displayed PCOS morphology.

Conclusion: Obesity has effect on the occurrence of sub-fertility and polycystic ovary syndrome at all reproductive ages.

Metrics

Metrics Loading ...

References

World Health Organization. Obesity and overweight fact sheet. WHO, 2016. (Accessed Dec19, 2019, at http://www.who.int/mediacentre/factsheets/fs311/en/.

Wyatt HR. Update on treatment strategies for obesity. J Clin Endocrinol Metab 2013; 98:1299–3. https://doi.org/10.7326/0003-4819-159-11-201312030-00016

Talmor A,Dunphy B. Female obesity and infertility. Best Pract Res Clin Obstet Gynaecol. 2015; 29(4):498–5. https://doi.org/10.1016/j.bpobgyn.2014.10.014

Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 2018; 14(5):270–84. https://doi.org/10.1038/nrendo.2018.24

Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod 2012; 27(10):3067–73. https://doi.org/10.1093/humrep/des232

Best D, Avenell A, Bhattacharya S. How effective are weight-loss interventions for improving fertility in women and men who are overweight or obese? A systematic review and meta-analysis of the evidence. Hum Reprod Update 2017; 23(6):681–5. https://doi.org/10.1093/humupd/dmx027

Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol 2018; 16(1):22. https://doi.org/10.1186/s12958-018-0336-z

Pantasri T, Norman RJ. The effects of being overweight and obese on female reproduction: a review. Gynecol Endocrinol 2014; 30(2):90–4. https://doi.org/10.3109/09513590.2013.850660

Jungheim ES, Travieso JL, Hopeman MM. Weighing the impact of obesity on female reproductive function and fertility. Nutr Rev 2013; 71(1):3–8. https://doi.org/10.1111/nure.12056

Deans R. Polycystic ovary syndrome in adolescence. Med Sci 2019; 7:101. https://doi.org/10.3390/medsci7100101

Witchel SF, E Oberfield S, Peña AS. Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls. J Endocr Soc 2019; 3:1545–3. https://doi.org/10.1210/js.2019-00078

Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: What’s new?. Adv Clin Exp Med 2017; 26:359–67. doi: 10.17219/acem/59380

Ganie MA, Vasudevan V, Wani IA, Baba MS, Arif T, Rashid A. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J Med Res 2019; 150:333–4. https://doi.org/10.4103/ijmr.IJMR_1937_17

Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics. Metab 2019; 92:108–20. https://doi.org/10.1016/j.metabol.2018.11.002

Damone AL, Joham AE, Loxton D, Earnest A, Teede HJ, Moran LJ. Depression, anxiety and perceived stress in women with and without PCOS: A community-based study. Psychol Med 2019; 49:1510–20. https://doi.org/10.1017/S0033291718002076

Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol 2018; 89:251–8. https://doi.org/10.1093/humrep/dey256

Greenwood EA, Huddleston HG. Insulin resistance in polycystic ovary syndrome: Concept versus cutoff. Fertil Steril 2019; 112:827–8. https://doi.org/10.1016/j.fertnstert.2019.08.100

Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev 2016; 37:467–520. https://doi.org/10.1210/er.2015-1104

Jeanes Y, Reeves S. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: Diagnostic and methodological challenges. Nutr Res Rev 2017; 30:97–105. https://doi.org/10.1017/S0954422416000287

Zhang C, Hu J, Wang W, Sun Y, SunK. HMGB1-induced aberrant autophagy contributes to insulin resistance in granulosa cells in PCOS. FASEB J 2020; 34(7):9563–74. doi: 10.1096/fj.202000605RR.

He FF, Li YM. Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: A review. J Ovarian Res 2020; 13:1–13. doi: 10.1186/s13048-020-00670-3

Li Y, Chen C, Ma Y, Xiao J, Luo G, Li Y, et al. Multi-system reproductive metabolic disorder: Significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci 2019; 228:167–75. https://doi.org/10.1016/j.lfs.2019.04.046

Palomba S, Falbo A, Chiossi G, Orio F, Tolino A, Colao A, et al. Low-grade chronic inflammation in pregnant women with polycystic ovary syndrome: a prospective controlled clinical study. J Clin Endocrinol Metab 2014; 99(8):2942–51. https://doi.org/10.1210/jc.2014-1214

World Health Organization. Infertility definitions and terminology, 2013. (Accessed June 26, 2022, at http://www.who.int/reproductivehealth/topics/infertility/definitions/en/index.ht ml.

MitalP, Shefali J, Dinesh J, BhaveshP, Nandini P, Priti V, et al. Prevalence of different factors responsible for infertility. Res J Recent Sci 2012; 1 (ISC-2011):207–11.

Hampton KD, Mazza D, Newton JM. Fertility‐awareness knowledge, attitudes, and practices of women seeking fertility assistance. J Adv Nurs Nrs 2013; 69(5):1076–84. https://doi.org/10.1111/j.1365-2648.2012.06095.x

World Health Organization. Obesity and overweight. Geneva: WHO, 2020. (Accessed June 28, 2022, at https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

Flegal KM, Carroll MD, Ogden CL,Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303(3):235–41. https://doi.org/10.1001/jama.2009.2014

Shah DK, Ginsburg ES. Bariatric surgery and fertility. Curr Opin Obstet Gynecol 2010; 22(3):248–4. https://doi.org/10.1097/GCO.0b013e3283373be9

Conner SN, Tuuli MG, Longman RE, Odibo AO, Macones GA, Cahill AG, et al. Impact of obesity on incision-todelivery interval and neonatal outcomes at cesarean delivery. Am J Obstet Gynecol 2013; 209(4):366–86. https://doi.org/10.1016/j.ajog.2013.05.054

Al-Hakmani FM, Al-Fadhil FA, Al-Balushi LH, Al-Harthy NA, Al-Bahri ZA, Al-RawahiNA, et al. The effect of obesity on pregnancy and its outcome in the population of Oman, Seeb Province. Oman Med J 2016; 31:12–7. https://doi.org/10.5001/omj.2016.03

Jungheim ES, Travieso JL, Hopeman MM. Weighing the impact of obesity on female reproductive function and fertility. Nutr Rev 2013; 71: S3–8. https://doi.org/10.1111/nure.12056

Machtinger R, Combelles CM, Missmer SA, Correia KF, Fox JH, Racowsky C et al. The association between severe obesity and characteristics of failedfertilized oocytes. Hum Reprod 2012; 27:3198–207. https://doi.org/10.1093/humrep/des308

Broughton DE, Jungheim ES. A focused look at obesity and the preimplantation trophoblast. Semin Reprod Med 2016; 34:5–10. https://10.1055/s-0035-1570032

Downloads

Published

2024-12-19

How to Cite

Saadi Ali , P. ., & Alsakkal, G. . (2024). Obesity in women of reproductive age and its relation to polycystic ovarian syndrome and sub-fertility . Zanco Journal of Medical Sciences (Zanco J Med Sci), 28(3), 510–517. https://doi.org/10.15218/zjms.2024.51

Issue

Section

Original Articles